Abbott said it would enter the laser cataract surgery business by buying privately held OptiMedica Corp. for up to $400 million and in a separate deal would pay $310 million for stent maker Idev Technologies.
Abbott to buy cataract laser, leg stent businesses
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.